Tofacitinib Citrate (CAS 540737-29-9)
« Back to Anti-Rheumatism API
Tofacitinib Citrate
CAS No. 540737-29-9
枸橼酸托法替布
Chemical structure
| CAS No. | 540737-29-9 |
|---|---|
| Synonyms | (3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3-propanetricarboxylate; CP 690500-10 |
| Category | Anti-Rheumatism API / Anti-Rheumatism |
| Assay / Purity | 99% |
| Molecular Formula | C22H28N6O8 |
| Molecular Weight | 504.5 |
| Melting Point | — |
| Boiling Point | — |
| Density | — |
| Flash Point | — |
| Appearance | Off-white to white solid powder |
Application and positioning
Tofacitinib citrate is a JAK1/JAK3 inhibitor supplied as the citrate salt. It is used in oral tablets for rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.
Quality and documentation
- Batch-specific Certificate of Analysis issued by the manufacturing site
- SDS/MSDS and specification sheet available on request
- Residual solvents and elemental impurities statements discussed per project
- For pharmaceutical manufacturing and R&D use only — not for direct administration
Packaging and handling
- Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
- Small quantities in sealed aluminium foil bags
- Palletised for air and sea freight; store dry, ventilated and protected from light
Related products
- Baricitinib (CAS 1187594-09-7)
- Methotrexate (CAS 59-05-2)
- Upadacitinib (CAS 1310726-60-3)
- (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine (CAS 477600-70-7)
Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.
Interested in this product?
Contact us for price, COA, MSDS and lead time — custom synthesis available.
Request a QuoteReference: CAS 540737-29-9 · PubChem CID 10174505